NCT06501196
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06501196
Title A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BlossomHill Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Medical Center RECRUITING Duarte California 91010 United States Details
University of California Los Angeles RECRUITING Los Angeles California 90095 United States Details
Stanford Cancer Center RECRUITING Palo Alto California 94304 United States Details
Sylvester Comprehensive Cancer Center RECRUITING Miami Florida 33136 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion RECRUITING Chicago Illinois 60611 United States Details
Roswell Park Cancer Institute RECRUITING Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
The Ohio State University Wexner Medical Center - James Cancer Hosp RECRUITING Columbus Ohio 43210 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
The University of Texas M.D. Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
University of Wisconsin Clinical Science Center RECRUITING Madison Wisconsin 53792 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field